-
EP3777845
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP Citations: EP3777845
| Cited in | Search | Type: | Patent literature | Publication No.: | WO2013079964
[XP] (ASTRAZENECA AB et al.) | Type: | Patent literature | Publication No.: | WO2012158884
[XP] (TAKEDA PHARMACEUTICAL et al.) | Type: | Non-patent literature | Publication information: | [XY] SMITH M R ET AL: "ARN-509 IN MEN WITH HIGH RISK NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER", ANNALS OF ONCOLOGY; ABSTRACT BOOK OF THE 37TH ESMO CONGRESS, KLUWER, DORDRECHT, NL; VIENNA, AUSTRIA, vol. 23, no. Suppl. 9, 1 September 2012 (2012-09-01), pages 303, XP008166216, ISSN: 0923-7534, DOI: 10.1093/ANNONC/MDS400 | DOI: | http://dx.doi.org/10.1093/annonc/mds400 | Type: | Non-patent literature | Publication information: | [XY] CLEGG NICOLA J ET AL: "ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment", CANCER RESEARCH, vol. 72, no. 6, March 2012 (2012-03-01), pages 1494 - 1503, XP008166073, ISSN: 0008-5472 | DOI: | http://dx.doi.org/10.1158/0008-5472.CAN-11-3948 | Type: | Non-patent literature | Publication information: | [A] REAGAN-SHAW S ET AL: "Dose translation from animal to human studies revisited", FASEB JOURNAL, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, US, vol. 22, 1 January 2007 (2007-01-01), pages 659 - 661, XP007916336, ISSN: 0892-6638 | Type: | Non-patent literature | Publication information: | [XY] TRAN CHRIS ET AL: "Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer", SCIENCE (WASHINGTON D C), vol. 324, no. 5928, May 2009 (2009-05-01), pages 787 - 790, XP002696684, ISSN: 0036-8075 | DOI: | http://dx.doi.org/10.1126/science.1168175 | Type: | Non-patent literature | Publication information: | [XY] KLIMENT JAN: "Re: Salvage Therapy With Bicalutamide 150 mg in Nonmetastatic Castration-resistant Prostate Cancer", EUROPEAN UROLOGY, vol. 59, no. 6, June 2011 (2011-06-01), pages 1066 - 1067, XP055090937, ISSN: 0302-2838 | DOI: | http://dx.doi.org/10.1016/j.eururo.2011.03.041 | Type: | Non-patent literature | Publication information: | [X] HEATH ELISABETH I ET AL: "A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3 '-Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer", AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, vol. 2, no. 4, 2010, pages 402 - 411, XP008166075, ISSN: 1943-8141 | Type: | Non-patent literature | Publication information: | [Y] ALVIN Y. LIU ET AL: "Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines", THE PROSTATE, vol. 60, no. 2, 1 January 2004 (2004-01-01), US, pages 98 - 108, XP055439461, ISSN: 0270-4137, DOI: 10.1002/pros.20031 [Y] 1-20 * the whole document * | DOI: | http://dx.doi.org/10.1002/pros.20031 | Type: | Non-patent literature | Publication information: | [Y] NATHAN LAWRENTSCHUK ET AL: "Efficacy of a Second Line Luteinizing Hormone-Releasing Hormone Agonist After Advanced Prostate Cancer Biochemical Recurrence", JOURNAL OF UROLOGY, vol. 185, no. 3, March 2011 (2011-03-01), pages 848 - 854, XP028358931, ISSN: 0022-5347, [retrieved on 20101101], DOI: 10.1016/J.JURO.2010.10.055 [Y] 1-20 * the whole document * | DOI: | http://dx.doi.org/10.1016/j.juro.2010.10.055 | Cited in | Examination | Type: | Non-patent literature | Publication information: | CLEGG NICOLA J ET AL: "Development of anti-androgen ARN-509 1 Supplemental Materials and Methods", CANCER RESEARCH, 1 March 2012 (2012-03-01), pages 1 - 13, XP055944437, Retrieved from the Internet | Type: | Non-patent literature | Publication information: | ANONYMOUS : "HIGHLIGHTS OF PRESCRIBING INFORMATION XTANDI", 1 July 2018 (2018-07-01), pages 1 - 29, XP055944718, Retrieved from the Internet | Type: | Non-patent literature | Publication information: | MICHAEL T. SCHWEIZER ET AL: "Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born", THERAPEUTIC ADVANCES IN UROLOGY, vol. 4, no. 4, 1 August 2012 (2012-08-01), GB, pages 167 - 178, XP055683017, ISSN: 1756-2872, DOI: 10.1177/1756287212452196 | DOI: | http://dx.doi.org/10.1177/1756287212452196 | Cited in | by applicant | Type: | Non-patent literature | Publication information: | NAT. MED, vol. 10, 2004, pages 33 - 39 | Type: | Non-patent literature | Publication information: | SCIENCE, vol. 324, no. 5928, 8 May 2009 (2009-05-08), pages 787 - 90 | Type: | Non-patent literature | Publication information: | J CLIN ONCOL, vol. 11, no. 8, 1993, pages 1566 - 72 | Type: | Non-patent literature | Publication information: | CLEGG ET AL., CANCER RES, vol. 72, 15 March 2012 (2012-03-15), pages 1494 | Type: | Non-patent literature | Publication information: | "Remington: The Science and Practice of Pharmacy", 1995, MACK PUBLISHING COMPANY | Type: | Non-patent literature | Publication information: | HOOVER, JOHN E.: "Remington's Pharmaceutical Sciences", 1975, MACK PUBLISHING CO. | Type: | Non-patent literature | Publication information: | "Pharmaceutical Dosage Forms", 1980, MARCEL DECKER | Type: | Non-patent literature | Publication information: | "Pharmaceutical Dosage Forms and Drug Delivery Systems", 1999, LIPPINCOTT WILLIAMS & WILKINS |